Study Spotlight

Study Spotlight

Fish Oil May Benefit Patients Following Esophageal Cancer Surgery


In a pilot study involving 60 patients with esophageal cancer divided into 2 groups, adding omega-3 polyunsaturated fatty acids to parenteral nutrition was found to be associated with significant reductions in inflammation (serum procalcitonin level was notably lower and CD4(=)/CD8(+) ratio was markedly higher in the omega-3 PUFAs group on post-operative day 6) and improvements in immune function, following esophageal cancer surgery. The authors state, "A larger trial is required to see whether omega-3 PUFAs supplementation of PN improves the clinical outcomes of patients following esophageal cancer surgery.

Click Here to visit the journal website. Subscription required to view the full text of the article.

Socialize
Website by Webfitters